Table of Contents Author Guidelines Submit a Manuscript
Journal of Obesity
Volume 2011 (2011), Article ID 953410, 3 pages
http://dx.doi.org/10.1155/2011/953410
Research Article

Serum Resistin Level in Obese Male Children

Department of Pediatrics, Namazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran

Received 26 October 2010; Accepted 26 January 2011

Academic Editor: Gianluca Iacobellis

Copyright © 2011 Anis Amirhakimi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Liu, Q. Wang, Y. B. Pan, Z. J. Gao, Y. F. Liu, and S. H. Chen, “Effects of over-expressing resistin on glucose and lipid metabolism in mice,” Journal of Zhejiang University: Science B, vol. 9, no. 1, pp. 44–50, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. H. Sinorita, R. H. Asdie, R. B. Pramono, L. B. Purnama, and A. H. Asdie, “Leptin, adiponectin and resistin concentration in obesity class I and II at Sardjito Hospital Yogyakarta,” Acta Medica Indonesiana, vol. 42, no. 2, pp. 74–77, 2010. View at Google Scholar
  3. Z. T. Bloomgarden, “Adiposity and diabetes,” Diabetes care, vol. 25, no. 12, pp. 2342–2349, 2002. View at Google Scholar · View at Scopus
  4. C. M. Kusminski, P. G. McTernan, and S. Kumar, “Role of resistin in obesity, insulin resistance and Type II diabetes,” Clinical Science, vol. 109, no. 3, pp. 243–256, 2005. View at Publisher · View at Google Scholar · View at PubMed
  5. R. Baratta, S. Amato, C. Degano et al., “Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2665–2671, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. J. Vendrell, M. Broch, N. Vilarrasa et al., “Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity,” Obesity Research, vol. 12, no. 6, pp. 962–971, 2004. View at Google Scholar · View at Scopus
  7. O. Ukkola, “Resistin—a mediator of obesity-associated insulin resistance or an innocent bystander?” European Journal of Endocrinology, vol. 147, no. 5, pp. 571–574, 2002. View at Google Scholar · View at Scopus
  8. C. L. McTernan, P. G. McTernan, A. L. Harte, P. L. Levick, A. H. Barnett, and S. Kumar, “Resistin, central obesity, and type 2 diabetes,” Lancet, vol. 359, no. 9300, pp. 46–47, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. A. R. Shuldiner, R. Yang, and DA. W. Gong, “Resistin, obesity, and insulin resistance—the emerging role of the adipocyte as an endocrine organ,” New England Journal of Medicine, vol. 345, no. 18, pp. 1345–1346, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. P. A. Kern, G. B. Di Gregorio, T. Lu, N. Rassouli, and G. Ranganathan, “Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-α expression,” Diabetes, vol. 52, no. 7, pp. 1779–1785, 2003. View at Google Scholar · View at Scopus
  11. Y. H. Yu and H. N. Ginsberg, “Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue,” Circulation Research, vol. 96, no. 10, pp. 1042–1052, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. K. F. Petersen and G. I. Shulman, “Etiology of insulin resistance,” American Journal of Medicine, vol. 119, no. 5, pp. S10–S16, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. C. M. Rondinone, “Adipocyte-derived hormones, cytokines, and mediators,” Endocrine, vol. 29, no. 1, pp. 81–90, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Ronti, G. Lupattelli, and E. Mannarino, “The endocrine function of adipose tissue: an update,” Clinical Endocrinology, vol. 64, no. 4, pp. 355–365, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. K. C. Lewandowski, K. Szosland, C. O'Callaghan, B. K. Tan, H. S. Randeva, and A. Lewinski, “Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices,” Molecular Genetics and Metabolism, vol. 85, no. 1, pp. 61–69, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. T. Yamauchi, J. Kamon, H. Waki et al., “The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity,” Nature Medicine, vol. 7, no. 8, pp. 941–946, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. B. B. Kahn and J. S. Flier, “Obesity and insulin resistance,” Journal of Clinical Investigation, vol. 106, no. 4, pp. 473–481, 2000. View at Google Scholar · View at Scopus
  18. J. M. Friedman, “The function of leptin in nutrition, weight, and physiology,” Nutrition Reviews, vol. 60, no. 10, pp. S1–S14, 2002. View at Google Scholar · View at Scopus
  19. G. Gonullu, H. Kahraman, A. Bedir, A. Bektas, and I. Yücel, “Association between adiponectin, resistin, insulin resistance, and colorectal tumors,” International Journal of Colorectal Disease, vol. 25, no. 2, pp. 205–212, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. N. Shojima, H. Sakoda, T. Ogihara et al., “Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells,” Diabetes, vol. 51, no. 6, pp. 1737–1744, 2002. View at Google Scholar · View at Scopus
  21. D. B. Savage, C. P. Sewter, E. S. Klenk et al., “. Resistin/FIZZ3 expression in relation to obesity and peroxisome proliferator-activated receptor-γ action in humans,” Diabetes, vol. 50, no. 10, pp. 2199–2202, 2001. View at Google Scholar · View at Scopus